Author

Laura Springgay

Vaccine and Gene Therapy Institute, Oregon Health & Science University;Primary ORCID profile (0000-0001-9457-2146 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Laura SpringgayiD2 papers · Vaccine and Gene Therapy Institute

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Abhishek Chanda· 1 shared Aleksandra E. SikoraiD· 1 shared Andrew N Macintyre· 1 shared Chenwei Lin· 1 shared Ian P Rose· 1 shared Ines A Cadena· 1 shared Jinu Abraham· 1 shared Junaid Nazir· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Abhishek Chanda

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mucosal ACP subunit vaccine formulated with a small molecule STING agonist drives protective TH1/TH17 responses and serum bactericidal antibodies against Neisseria gonorrhoeae

Abhishek Chanda, Ines A Cadena, Junaid Nazir, Laura Springgay, Ian P Rose, Jinu Abraham, Chenwei Lin, Mansab Ali Saleemi, Andrew N Macintyre, Victor R. DeFilippis, Aleksandra E. Sikora

This study evaluates a mucosal vaccine combining ACP and diABZI, showing enhanced TH1/TH17 responses and serum bactericidal activity against Neisseria gonorrhoeae.

bioRxiv · Nov 3, 2026 · PreprintMicrobiology